MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-13-2025
iCAD Retained Earnings 2011-2026 | ICAD
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings iCAD
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -277 M | -272 M | -267 M | -253 M | -242 M | -224 M | -211 M | -202 M | -188 M | -178 M | -145 M | -144 M | -136 M | -127 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -127 M | -277 M | -205 M |
Quarterly Retained Earnings iCAD
| 2025-Q1 | 2024-Q4 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -278 M | -277 M | -275 M | - | -272 M | -272 M | -271 M | -267 M | -264 M | -260 M | -257 M | -253 M | -249 M | -247 M | -244 M | -242 M | -242 M | -242 M | -242 M | -224 M | -224 M | -224 M | -224 M | -211 M | -211 M | -211 M | -211 M | -202 M | -202 M | -202 M | -202 M | -188 M | -188 M | -188 M | -188 M | -178 M | -178 M | -178 M | -178 M | -145 M | -145 M | -145 M | -145 M | -144 M | -144 M | -144 M | -144 M | -136 M | -136 M | -136 M | -136 M | -127 M | -127 M | -127 M | -127 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -127 M | -278 M | -201 M |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-372 M | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B | USA |
 |
HealthStream
HSTM
|
109 M | $ 21.2 | 1.1 % | $ 644 M | USA |
 |
American Well Corporation
AMWL
|
-2.06 B | $ 5.7 | -1.04 % | $ 91.5 M | USA |
 |
Computer Programs and Systems
CPSI
|
8.13 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
NextGen Healthcare
NXGN
|
129 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
-485 M | - | - | $ 2.33 B | USA |
 |
Omnicell
OMCL
|
383 M | $ 34.99 | 1.54 % | $ 1.61 B | USA |
 |
Phreesia
PHR
|
-743 M | $ 11.25 | -0.27 % | $ 614 M | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 7.25 | 6.93 % | $ 124 M | USA |
 |
Evolent Health
EVH
|
-606 M | $ 2.27 | 0.67 % | $ 213 M | USA |
 |
Schrödinger
SDGR
|
-629 M | $ 11.48 | -0.78 % | $ 843 M | USA |
 |
MTBC
MTBC
|
-55.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
Teladoc Health
TDOC
|
-16.4 B | $ 5.59 | 3.04 % | $ 985 M | USA |
 |
GoodRx Holdings
GDRX
|
-1.44 B | $ 2.07 | 1.23 % | $ 798 M | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
SCWorx Corp.
WORX
|
-31 M | $ 0.13 | 2.6 % | $ 190 K | USA |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
-67.7 M | - | - | $ 161 M | USA |
 |
Zhongchao
ZCMD
|
-7.96 M | $ 1.85 | 2.16 % | $ 9.63 M |  China |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
Health Catalyst
HCAT
|
-1.36 B | $ 1.1 | 0.46 % | $ 76.9 M | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
196 M | $ 82.31 | 0.26 % | $ 7.09 B | USA |
 |
10x Genomics
TXG
|
-1.28 B | $ 20.82 | 5.07 % | $ 2.44 B | USA |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
144 M | $ 17.76 | -1.63 % | $ 1.52 B | USA |
 |
So-Young International
SY
|
-926 M | $ 3.16 | 8.59 % | $ 251 M | China |
 |
Veeva Systems
VEEV
|
4.36 B | $ 178.3 | -0.45 % | $ 29.2 B | USA |